Hybrid Open-endovascular Repair for Thoracoabdominal Aortic Aneurysms: Current Status and Level of Evidence  by Donas, K.P. et al.
Eur J Vasc Endovasc Surg 34, 528e533 (2007)
doi:10.1016/j.ejvs.2007.05.023, available online at http://www.sciencedirect.com on
1REVIEW
Hybrid Open-endovascular Repair for Thoracoabdominal Aortic
Aneurysms: Current Status and Level of Evidence
K.P. Donas,1* M. Czerny,1 I. Guber,1 H. Teufelsbauer2 and J. Nanobachvili2
Departments of 1Cardiothoracic Surgery, and
2Vascular Surgery, Medical University of Vienna, Vienna, Austria
Purpose. To report the results of a systematic review of the literature and to provide evidence for the hybrid open-
endovascular repair (HOER) in patients with thoracoabdominal aortic aneurysms (TAAAs).
Methods. A comprehensive literature review was performed and all studies identified that reported the results of HOER in
patients with TAAA and information about primary technical and clinical success in evaluating the immediate and long-
term complications such as neurological, renal and respiratory morbidity. All studies were reviewed by two independent
observers for the above mentioned parameters.
Results. After careful selection according to the given criteria, 13 studies were included in our statistical analysis. The
number of reported patients totalled 58. Of those, 37 were men (64.4%) and the mean age of the patients was 68.1 years
(range 35e80, 95%CI [72.8, 64.9]). All patients were unfit for open repair with severe comorbidities. The mean follow-up
period was 14.5þ/ 8.7 months (range 4e36, 95%CI [18.7, 9.9]) and the mean aneurysm diameter was 7.15 cm (range 5
to 12, 95%CI [7.87, 6.69]). 229 (97.8%) of the 234 visceral vessel grafts remained patent during the follow-up period.
Reintervention was necessary in one (1.6%) of the five patients with an occluded graft. The overall long-term endoleak
rate was 20.6% (12/58 patients) and the reintervention rate was 13.7% (8/58 patients). No patients developed proce-
dure-related neurological deficits. The overall early and long-term mortality rate for completed procedures was 15.5%
(9/58).
Conclusions. HOER shows promising mid-term results for high-risk patients who have TAAA, however, present evidence
does not allow robust conclusions.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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In recent years, advances in surgical techniques and
organ protection methods have led to better outcomes
for the open repair of thoracoabdominal aortic aneu-
rysms (TAAA), but severe neurological, renal and
respiratory morbidity still occur in some patients.1,2
In 1991 Parodi3 reported the endovascular repair of
abdominal aortic aneurysms and ushered in the endo-
vascular era in the treatment of aneurysms. In 2001
Chuter4,5 described the first case of total endovascular
repair of TAAA, complicated by spinal cord ischemia.
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time-consuming nature of the procedure and the ex-
position of the vascular specialist to high radiation
doses remain severe disadvantages of the fenestrated
and branched stent-grafts.
The hybrid open-endovascular repair (HOER), i.e.
open visceral vessels debranching and subsequent en-
dovascular exclusion of the TAAA, offers a possible
alternative treatment option for patients who are unfit
for the open repair or who have unfavourable ana-
tomy for total endovascular therapy.
We performed a systematic review focusing on the
primary and follow-up technical and clinical success
of HOER in terms of neurological, renal, respiratory
morbidity, graft durability and endoprosthesis-related
complications.lar Surgery. Published by Elsevier Ltd. All rights reserved.
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Search strategy
An extensive search of the literature published be-
tween January 1999 and October 2006 was performed
using PubMed. Additionally, the reference lists of all
included articles were examined for further relevant
references. A further search of relevant general medi-
cal and specific journals was conducted by hand. All
studies were independently assessed by 2 reviewers
for inclusion and exclusion criteria and the full text
of these studies were retrieved.
Study eligibility
Studies were included if the following criteria were
fulfilled: (1) TAAA was diagnosed on the basis of
the Crawford classification, modified by Safi, (2)
HOER (visceral bypass followed by endovascular
stent-graft implantation) was the intended repair
strategy and was completed in all patients, (3) there
had been a minimum follow-up period of 4 months,
(4) diagnosis of complex TAAA had been made
according to computed tomographic (CT) scans of
the thorax, abdomen and pelvis, (5) at least one
of the basic outcome criteria (neurological, renal, re-
spiratory morbidity, visceral vessel patency and
endoprosthesis related complications, as well as the
primary technical success rate, and the total mortality
rate were stated. Articles were excluded if TAAA re-
pair was only by surgical or endovascular approaches
alone.
Data extraction and analysis
For each study the following data were extracted by
two independent reviewers: number of patients, sex,
mean age (years); primary technical success; 30 days
clinical success; stentgraft design; mean follow-up
period (months); neurological, renal, respiratory
morbidity; visceral vessel patency and endoprosthesis
related complications; reinterventions and the proce-
dure- related and total follow-up mortality. Where
disparate results were reported by the two observers
extracting the data, the publications were re-analyses
and consensus reached. Primary technical success and
30-day clinical success included events which
occurred within the first 24 hours and 30 days after
intervention, respectively.Patient selection criteria
The patients were all deemed unfit for open surgical
approach. This category included patients who could
not tolerate aortic cross-clamping or open thoracot-
omy due to prior aneurysmal repairs and/or having
severe medical comorbidities, such as chronic obstruc-
tive disease (COPD), coronary artery disease (CAD),
congestive heart failure (CAF), diabetes mellitus
(DM), and hypertension (HN). None of these patients
was an exclusively endovascular candidate, due to
marked arterial tortuosity, severe angulation of the
aorto-iliac system, or involvement of the aortic side
branches in the aneurysm. Patients who suffered
from isolated aortic arch or descending aneurysms,
acute or chronic aortic dissections or traumatic trans-
actions and connective tissue disorders, such as Mar-
fan syndrome and Ehlers-Danlos syndrome were
excluded from the study. Additionally, cases with aor-
tic para-anastomotic pseudoaneurysm after previous
surgical repair of TAAA were not included in the
present review.
The definition of the TAAAwas made according to
the Crawford classification, modified by Safi.7 Type I
TAAA extends from the proximal descending aorta
to the upper abdominal aorta; Type II TAAA from
the proximal descending thoracic aorta to below the
renal arteries; Type III TAAA from the distal half of
the descending thoracic aorta into the abdomen;
Type IV involves the majority of the entire abdominal
aorta. In 1999, Safi added a fifth type to the origin four
which extends from the 6th intercostals space to just
above the renal arteries.
Statistical analysis
All numeric values are stated as mean þ/ standard
error in parenthesis.
Results
Our electronic literature search identified 27 studies.
After additional searches by hand and careful selec-
tion in accordance with the inclusion criteria, 13
studies9e21 were included in our statistical analysis.
Detailed data is provided in Table 1. The number of
reported patients totalled 58. Of those 37 were men
(64.4%) and the mean age of the patients was 68.8
years (range 35e80, median 69.6, 95%CI [72.8, 64.9]).
15 TAAAs were of type I, 21 of type II, 11 of type
III, 6 of type IV and 5 of type V. The mean follow-up
period was 14.3þ/ 8.4 months (range 4e36, median
12 months, 95%CI [18.7, 9.9]) and the mean aneurysm
530 K. P. Donas et al.diameter was 7.15 cm (range 5 to 12, median 7.5 cm,
95%CI [7.87, 6.69]).
Primary technical, 30-days clinical success and
long-term clinical outcome
Primary technical success was achieved in all 58 pa-
tients (100%). The most commonly used stent-graft
designs were Talent (n¼ 25, Medtronic, Inc.; Minne-
apolis, Minn), Excluder (n¼ 16, W. L. Gore & Associ-
ates, Newark, DE, US), Zenith (n¼ 5, Cook
Endovascular, Bloomington, IN, US), Gianturco stain-
less-steel Z (n¼ 5, Cook Group, Inc, Bloomington,
Ind), Jotec E-vita (n¼ 1, Jotec, Hechingen, Germany),
Corvita Endoluminal Graft (CEG) Tubular Aortic En-
doprosthesis (n¼ 1, Schneider, Minneapolis, Minn),
and Talent stent-grafts combined with Excluder grafts
(used in 3 patients). For two patients no specific name
of the device type was reported in the published cases
(Table 2). During the first 30 days after the hybrid
Table 1. The studies about ‘‘completed hybrid procedure for
patients with TAAAs’’ whichwere included in the review-analysis
Authors Year Location fu n 0e30
d mortality
Black et al. 2006 London/UK 8 26 6
Flye et al. 2004 St.Louis, Mo/USA 14.6 3 0
Donas, et al. 2007 Cologne/Germany 21 8 1
Chiesa, et al. 2004 Milan/Italy 12 1 0
Macierewicz,
et al.
2000 Nottingham/UK 22 1 0
Quin˜ones-
Baldrich, et al.
1999 LA, Calif/USA 6 1 0
Lawrence-Brown,
et al.
2000 Perth/Australia 36 2 0
Kotsis, et al. 2003 Ulm/Germany 14 4 1
Agostinelli, et al. 2002 Parma/Italy 6 1 0
Iguro, et al. 2003 Kagoshima/Japan 12 1 0
Saccani, et al. 2002 Parma/Italy 4 3 1
Khoury, et al. 2002 Detroit/USA 21 1 0
Gawenda, et al. 2006 Cologne/Germany 12 6 0
fu- follow-up, n-number of patients.
Table 2. The most commonly used stent-graft designs for the
endovascular exclusion of the thoracoabdominal aortic aneurysm
Stent-graft devices n
Talent (Medtronic, Inc.; Minneapolis, Minn) 25
Excluder (W.L. Gore & Associates, Newark, DE, US) 16
Zenith (Cook Endovascular, Bloomington, IN, US) 5
Gianturco stainless-steel Z
(Cook Group, Inc, Bloomington, Ind)
5
Jotec E-vita (Hechingen, Germany) 1
Corvita (Schneider Minneapolis Minn) 1
Talentþ Excluder 3
Unknown 2
n: number of stent-graft devices.Eur J Vasc Endovasc Surg Vol 34, November 2007procedure graft-related complications were reported
in 11 patients (18.9%). Six patients had type I endo-
leaks (10.3%), four had type II endoleaks (6.8%) and
one patient had a type III endoleak (1.7%). Of the
eleven patients who had initial type I endoleaks 5
(8.6%) required an early reintervention and one devel-
oped another type I leak at 1 year, all of which were
corrected via stent extensions. These procedures re-
sulted a decrease in the size of the leak and stable
sized aneurysm sac. One patient with distal type I en-
doleak (IB) was successfully treated with emboliza-
tion. For the patients with type II endoleak, all
except one had resolved on CT scan at 3 months.
The latter patient required occlusion coiling of the
left subclavian artery origin. The overall long-term en-
doleak rate was 20.6% (12/58 patients) and reinter-
vention was required in 13.7% of the patients (8/58
patients).
Graft patency
At a mean follow-up of 14.2 months (median 12
months, range, 4 to 36 months), 229 (97.8%) of the
234 hybrid surgical grafts remained patent (Table 3).
The superior mesenteric artery (SMA) graft occluded
in two patients and a single renal graft occluded in an-
other three. Further intervention was necessary in one
(1.6%) of the five patients with the occluded grafts
due to poor collateral supply of the SMA and the de-
velopment of progressive ischemic colitis. The SMA
graft thrombectomy was successful and the patient’s
post-operative course proved uneventful. With re-
gards to the other cases, one patient with SMA graft
occlusion showed good collateral supply via the celiac
artery and for the three patients with single renal graft
thrombosis, the patient’s other kidney remained in
good condition with a good functioning graft, and
no further intervention was pursued.
Morbidity
No patients developed paraplegia or other procedure-
related neurological deficits due to spinal cord injury
and ischemia. Two (3.4%) patients who underwent
renovisceral rebranching and subsequent endovascu-
lar exclusion of the aneurysm distal to the left subcla-
vian artery were found to have left hemispheric
emboli postoperatively with total resolution of hemi-
plegic symptoms in both before discharge. Major
adverse events included prolonged respiratory
support (>5 days) in 11 patients; prolonged inotropic
support (>4 days) in 4; renal impairment (eg> 25%
rise in creatinine) requiring temporary haemodialysis
531Hybrid Open-endovascular Repair for TAAAsTable 3. Visceral vessel grafts and patency rate during the follow up period
Graft Aorto-renal Aorto-mesenteric Aorto-celiac Iliaco- mesenteric Iliaco-celiac Iliaco-renal
Total 117 50 43 7 7 10
Occluded 3 2 0 0 0 0
Primary graft- patency 97.4% 96% 100% 100% 100% 100%Eur J Vasc Endovasc Surg Vol 34, November 2007in 3 and not requiring support in 2; ischemia of the left
colon requiring resection in 1, and prolonged ileus
(>7 days) in 3. In one further patient with an exten-
sive isolated type II TAAA secondary to a chronic
type B dissection, a type A dissection developed 10
days after the initial procedure and required an emer-
gency Bentall procedure. Another patient from the
Cologne patient-group11 had a myocardial infarction
3 days after the operation. Cardiac enzymes and
ECG changes returned to normal within a further 3
days. In summary, 28 (48.2%) patients had a major
complication after the combined procedure during
their hospital stay.
Mortality
Thirty-day elective and urgent mortality was 10.7%
(6/55). Three patients with a ruptured TAAAwho un-
derwent the HOER died. The overall early and long-
term mortality for completed procedures was 15.5%
(9/58). One patient (1.7%) developed ischemic-related
pancreatitis and did not respond to conservative treat-
ment. The patient died on the 6th postoperative day
(POD) following multiorgan failure. Immediate post-
operative diffuse retroperitoneal bleeding occurred
in one patient (1.7%). The patient developed multior-
gan failure. Another patient died from pulmonary
embolus on day 29 and one died as a result of myocar-
dial infarction on day 10. The fifth patient underwent
embolization after placement of visceral revasculari-
zation grafts. It is unclear if this complication oc-
curred after the passage of the stent-grafts through
the iliac system that supported the renovisceral re-
branching. The emboli resulted in widespread micro-
infarction in all the visceral beds. The last patient from
the elective and urgent group who died had intestinal
bleeding and bowel infarction of unknown aetiology
on the 12th POD.
From the three patients with ruptured TAAAs, one
died intraoperatively and two survived>10 days post-
operatively only to succumb to cardiac complications.
Two late complications occurred due to procedure
unrelated causes such as a ruptured ascending aortic
aneurysm 3 months after the operation in one case
and cardiac disease 3 years after the combined ap-
proach in the other case.Discussion
The results of elective surgical repair of TAAA have im-
proved considerably over the last 20 years. For example,
30-day mortality rate of 5.7%, paraplegia rate of 4.5%
and renal failure requiring dialysis of 6.0% were re-
cently reported.7 Nevertheless, there are several disad-
vantages to open TAAA repair including6e8 extensive
incisions for aneurysm exposure, temporary aortic
and visceral vessel occlusion, and the replacement of
long segments of the aorta. Several adjuncts have been
developed for open TAAA, including different types
of shunts, pumps (for peripheral perfusion) and contin-
uous neurological monitoring.8
Ultimately, cord injury after aortic surgical replace-
ment results from an ischemic insult that is caused
by temporary or permanent interruption of spinal
cord blood supply. Consistent with the hypothesis
that the duration of ischemia is an important predictor
of cord complications, the risk of treatment-related
cord injury clearly increases with the more extensive
TAAA types, i.e. types I and II. Svensson,22 detailing
Crawford’s open repair experience with more than
1500 patients with TAAA, noted a 24% incidence of
cord injury in types I and II TAAA, as compared
with 5.5% for types III and IV.
The sustained development of the endovascular
treatment of aneurysms made possible a combined
surgical and endovascular approach known as the
‘‘hybrid procedure’’ for extensive TAAAs. This
approach reduces the open procedural burden
by avoiding extensive thoraco-abdominal access.9,11,16
In addition, the total avoidance of high aortic cross
clamping allows a significant reduction of visceral
and renal ischemia time, which influences the appear-
ance of severe complications such as renal impairment
and dialysis.11Moreover, the performance of the proce-
dure under hemodynamically stable conditions
reduces the risk of neurological complications, such
as paraplegia and/or paraparesis.11
The literature provides scant information regard-
ing the immediate and long-term results of HOER
in patients suffering from TAAA, mostly in the
form of case reports and small patient series. There-
fore, this systematic review aims to demonstrate the
results of the published series under inclusion crite-
ria and to draw conclusions about the efficacy of
532 K. P. Donas et al.the HOER in TAAAs. In spite of 61% (36/58) of the
included patients treated with HOER having type I
and II TAAAs, there was no evidence of paraparesis
or paraplegia in any of the reported cases. This find-
ing has also been described in the series involving
a complete endovascular approach.3,4 The exclusion
of several factors using the combined technique,
facilitating the development of spinal cord ischemia,
such as intraoperative haemodynamic instability, re-
perfusion injuries with postoperative cord oedema
linked to a compartment-like syndrome within the
rigid confines of the bony canal and, of course, aortic
cross-clamping are likely important in the reduced
neurological complication rate. Recently, there has
been a report of a patient who underwent HOER suf-
fering from paraplegia and transient paraparetic
events postoperatively.23
The results of the primary graft patency rates are
very encouraging. At a mean follow-up of 14.2
months, 229 (97.8%) of the 234 grafts remained patent.
The superior mesenteric artery (SMA) graft occluded
in two patients and in only one (1.7%) of all patients
was a reoperation necessary, i.e. SMA bypass throm-
bectomy so as to prevent severe ischemic colitis.
Routes of visceral revascularisation are controversial
but if a retrograde visceral revascularization tech-
nique is used then it is ideal to pass the stent graft
via the contralateral iliac artery.8,11
The Achilles heel of the endovascular stent-graft
placement remains endoleaks. Dealing with proximal
type I endoleaks by use of proximal stent extension re-
quires the adjunctive transpositioning of vessels of the
aortic arch so as to create the necessary landing zone
for the thoracic endografts. Nevertheless, in spite of
crossover grafting it has been reported that with the
persistence of proximal type I endoleaks, there
remains the potential risk of rupture of the thoracic
aneurysm segment.8
Eleven patients (18.6%) of the 58 showed initial en-
doleaks. Six patients had type I endoleaks (10.3%),
four had type II endoleaks (6.8%) and one patient
type III endoleak (1.7%). At 1 year after the HOER an-
other patient developed a type I leak. Correction was
necessary in 6 cases by stent extensions. One patient
underwent carotid-carotid/subclavian crossover graft-
ing to create the necessary landing zone. The high inci-
dence of endoleaks reflects the difficulty in creating an
adequate landing zone for the graft and probably the
inappropriate design of current stent-graft for exten-
sive TAAAs.
The majority of the authors prefer to use the lower
aorta or common iliac artery for the origin of the ret-
rograde grafts. The results of the review justifies this
attitude because only 2 (3.4%) patients of the 58Eur J Vasc Endovasc Surg Vol 34, November 2007developed a distal type I endoleak and in only one
(1.7%) of them required treatment.
Even though, the number of patients with TAAA
treated by HOER is still low, and the period of fol-
low-up short, the preliminary results are encouraging.
The absence of severe neurological deficits in the
reported case histories clearly demonstrates the pre-
vention of spinal cord injury due to the avoidance of
cross clamp-induced spinal cord ischemia. Neverthe-
less, further studies are necessary to draw definitive
conclusions.
Conclusion
The present systematic review shows promising mid-
term outcomes for high-risk patients with TAAA
who underwent hybrid procedures (visceral bypass
followed by endovascular stent-graft implantation).
However, there is little data in the literature to support
the combined technique as better, worse, or equivalent
to the open repair or simply medical treatment alone.
Thus, the continued development of the endovascular
technologies and increasing experience in the com-
bined procedure are paramount to draw robust con-
clusions about the suggested alternative treatment
option in patients with challenging TAAAs.
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